Cargando…
SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia
Autores principales: | Finsterer, Josef, Maeztu, Concepción |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SEGG. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890342/ https://www.ncbi.nlm.nih.gov/pubmed/33610379 http://dx.doi.org/10.1016/j.regg.2021.01.001 |
Ejemplares similares
-
SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
por: Finsterer, Josef, et al.
Publicado: (2020) -
Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021) -
Myopathy or Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin
por: Finsterer, Josef, et al.
Publicado: (2020) -
Unvaccinated patients may still experience SARS-CoV-2 associated polyradiculitis
por: Finsterer, Josef
Publicado: (2022) -
SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause
Rhabdomyolysis
por: Finsterer, Josef
Publicado: (2021)